| Celecoxib studied in …STUDIED_INderived194 of 194show fewer |
|---|
| → studied in | NCT01356290Phase 2 · recruiting Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05756166Phase 1/Phase 2 · terminated Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer · 194 trials list this drug (15 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06942039early Phase 1 · recruiting Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation · 194 trials list this drug (15 active) | — | — | Central Nervous System Embryonal Tumor,Atypical Teratoid/Rhabdoid Tumor,Central Nervous System Embryonal Tumor with Rhabdoid Features+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06076837Phase 1 · terminated The Seven Trial: Exploiting the Unfolded Protein Response · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02885974Phase 1 · completed Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer · 194 trials list this drug (15 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07634094Phase 2 · not yet recruiting Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer · 194 trials list this drug (15 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00159484Phase 1/Phase 2 · completed Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm,Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01150045Phase 3 · completed Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06997068Phase 2 · recruiting Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population · 194 trials list this drug (15 active) | — | — | Malignant Head and Neck Neoplasm,Malignant Lip and Oral Cavity Neoplasm,Malignant Laryngeal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02115074Phase 1 · completed Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas · 194 trials list this drug (15 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03026140Phase 2 · recruiting Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer · 194 trials list this drug (15 active) | — | — | Colon Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05731726Phase 2 · recruiting Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer · 194 trials list this drug (15 active) | — | — | Rectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02574728Phase 2 · active not recruiting Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors · 194 trials list this drug (15 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04469530Phase 2 · recruiting Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors · 194 trials list this drug (15 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04093323Phase 2 · terminated Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma · 194 trials list this drug (15 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01881048early Phase 1 · completed Window of Opportunity Study Targeting the Inflammatory Milieu · 194 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07174570Phase 2 · recruiting Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer · 194 trials list this drug (15 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07154316Phase 2 · recruiting Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07150949Phase 2 · recruiting Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC) · 194 trials list this drug (15 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07104266Phase 2 · recruiting Triple Negative Breast Cancer and Celecoxib. Pilot Study · 194 trials list this drug (15 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06722534NA · recruiting Celecoxib for Prevention of Progression in Peutz-Jeghers Syndrome · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02030964Phase 1 · completed N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan · 194 trials list this drug (15 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04041050Phase 1 · active not recruiting A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm · 194 trials list this drug (15 active) | — | — | Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04162873Phase 2 · terminated Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer · 194 trials list this drug (15 active) | — | — | Malignant Laryngeal Neoplasm,Sinonasal Carcinoma,Laryngeal Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03084536Phase 2 · completed PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery · 194 trials list this drug (15 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05281276Phase 1 · terminated Chidamide + Celecoxib in Advanced Metastatic Colorectal Cancer (CCmCC) · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03643744Phase 1 · terminated Photodynamic Therapy-Induced Immune Modulation: Part III · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04176419Phase 3 · terminated Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00151476terminated Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878524Phase 1 · terminated Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial · 194 trials list this drug (15 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00665457Phase 2 · terminated Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery · 194 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04081389Phase 1 · completed Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer · 194 trials list this drug (15 active) | — | — | Early Stage Breast Carcinoma,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00846430Phase 2 · completed Medical Treatment of "High-Risk" Neurofibromas · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03599453early Phase 1 · completed Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer · 194 trials list this drug (15 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00538031Phase 2 · completed Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer · 194 trials list this drug (15 active) | — | — | Malignant Peritoneal Neoplasm,Malignant Fallopian Tube Neoplasm,Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00268476Phase 2/Phase 3 · active not recruiting Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy · 194 trials list this drug (15 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00503035Phase 2 · completed Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05438303Phase 1 · completed Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05327751Phase 3 · unknown Possible Protective Effect of Celecoxib Against Capecitabine Induced Hand and Foot Syndrome in Patients With Colorectal Cancer · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03403634Phase 2 · completed Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver · 194 trials list this drug (15 active) | — | — | Colorectal Neoplasm,Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02054104Phase 1/Phase 2 · terminated Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum · 194 trials list this drug (15 active) | — | — | Melanoma,Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02484664Phase 2 · completed COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC · 194 trials list this drug (15 active) | — | — | Lymphangioleiomyomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112502Phase 2 · completed Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme · 194 trials list this drug (15 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02770378Phase 1/Phase 2 · completed A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma · 194 trials list this drug (15 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00585312Phase 3 · terminated Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP) · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00033371Phase 2 · completed Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00020878Phase 2 · completed Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers · 194 trials list this drug (15 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00062179Phase 2 · completed Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer · 194 trials list this drug (15 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075673Phase 1 · terminated Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer · 194 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02151448Phase 1/Phase 2 · completed αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies · 194 trials list this drug (15 active) | — | — | Peritoneal Neoplasm,Peritoneal Malignant Mesothelioma,Peritoneal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02429427Phase 3 · completed European Celecoxib Trial in Primary Breast Cancer · 194 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01143545Phase 1 · terminated Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas · 194 trials list this drug (15 active) | — | — | Sarcoma,Malignant Esophageal Neoplasm,Malignant Lung Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01313429Phase 1 · terminated Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum · 194 trials list this drug (15 active) | — | — | Melanoma,Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02280694Phase 2 · completed Low Dose Metronomic Poly-chemotherapy for Metastatic CRC · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03896113Phase 2 · unknown Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma · 194 trials list this drug (15 active) | — | — | Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01258868Phase 1 · terminated Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas · 194 trials list this drug (15 active) | — | — | Malignant Esophageal Neoplasm,Malignant Lung Neoplasm,Thymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03185871Phase 2 · withdrawn Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses · 194 trials list this drug (15 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02108366Phase 3 · completed Treatment of Severe Influenza A Infection · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00037817Phase 1 · completed Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies · 194 trials list this drug (15 active) | — | — | Malignant Esophageal Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02961998Phase 4 · completed Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail · 194 trials list this drug (15 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03059238Phase 3 · completed Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure · 194 trials list this drug (15 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03864575Phase 2 · unknown An Open Label Phase II Study Combining Nivolumab and Celecoxib in Patients With Advanced " Cold " Solid Tumors · 194 trials list this drug (15 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03184493Phase 3 · unknown Celebrex and Metformin for Postoperative Hepatocellular Carcinoma · 194 trials list this drug (15 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00061893Phase 2 · completed Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors · 194 trials list this drug (15 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00022399Phase 2 · completed Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer · 194 trials list this drug (15 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00256321Phase 2 · terminated Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma · 194 trials list this drug (15 active) | — | — | Gastric Carcinoma,Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00685568Phase 1 · completed Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068432Phase 2 · completed Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer · 194 trials list this drug (15 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00080782Phase 2 · terminated Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases · 194 trials list this drug (15 active) | — | — | Malignant Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00088972Phase 2 · terminated S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women · 194 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01041781Phase 3 · terminated Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer · 194 trials list this drug (15 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01341496Phase 1 · terminated Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal · 194 trials list this drug (15 active) | — | — | Melanoma,Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02839694Phase 1 · withdrawn Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy · 194 trials list this drug (15 active) | — | — | Neoplasm,Melanoma,Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01220973Phase 2 · completed Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer · 194 trials list this drug (15 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01705106Phase 1 · terminated Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies · 194 trials list this drug (15 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00290680Phase 1 · completed Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors · 194 trials list this drug (15 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052611Phase 2 · completed Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia · 194 trials list this drug (15 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01284504NA · terminated Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm,Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00400374Phase 1 · completed Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2 · 194 trials list this drug (15 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01729923Phase 2 · terminated A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer · 194 trials list this drug (15 active) | — | — | Colon Carcinoma,Malignant Colon Neoplasm,Malignant Rectal Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01695226Phase 2 · completed Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer · 194 trials list this drug (15 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00137852Phase 2 · completed Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer · 194 trials list this drug (15 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00081263Phase 2 · completed Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia · 194 trials list this drug (15 active) | — | — | Cervical Carcinoma,Cervical Intraepithelial Neoplasia Grade 2/3,Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01425476Phase 1/Phase 2 · completed Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors · 194 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047281Phase 2 · completed Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047294Phase 2 · completed Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00081848Phase 1 · completed Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors · 194 trials list this drug (15 active) | — | — | Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00582660Phase 2 · completed Evaluation of Surgically Resected Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib · 194 trials list this drug (15 active) | — | — | Colorectal Adenoma,Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02840162Phase 2 · terminated Pre-Prostatectomy Celecoxib or Placebo · 194 trials list this drug (15 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00499655Phase 2 · completed Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer · 194 trials list this drug (15 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00520845Phase 2 · terminated Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer · 194 trials list this drug (15 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00953849Phase 1/Phase 2 · completed Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity · 194 trials list this drug (15 active) | — | — | Oral Cavity Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02401295Phase 1 · completed ATRA, Celecoxib, and Itraconazole as Maintenance · 194 trials list this drug (15 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00056082Phase 2 · completed Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women · 194 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045591Phase 2 · terminated Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer · 194 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00099047Phase 2 · completed Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma · 194 trials list this drug (15 active) | — | — | Multiple Myeloma,Smoldering Multiple Myeloma,Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070057Phase 1 · completed Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer · 194 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00081224Phase 2 · terminated Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00450736Phase 1 · completed Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery · 194 trials list this drug (15 active) | — | — | Sarcoma,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00291694Phase 2 · completed Protocol for Women at Increased Risk of Developing Breast Cancer · 194 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005878Phase 2 · completed Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus · 194 trials list this drug (15 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070486Phase 2 · completed Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer · 194 trials list this drug (15 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00931203Phase 2 · completed Trial of Celecoxib With Preoperative Chemo- Radiation for Locally Advanced Rectal Cancer · 194 trials list this drug (15 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02739204Phase 2 · unknown Concurrent Radiotherapy and/or Cisplatin With or Without Celecoxib in Patients With Primary Oral Squamous Cell Carcinoma · 194 trials list this drug (15 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00152828Phase 1/Phase 2 · completed Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the Cervix · 194 trials list this drug (15 active) | — | — | Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00305643Phase 3 · terminated Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer · 194 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00596219NA · completed Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma · 194 trials list this drug (15 active) | — | — | Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00046839Phase 1/Phase 2 · completed Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer · 194 trials list this drug (15 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085163Phase 3 · completed Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093678NA · withdrawn Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer · 194 trials list this drug (15 active) | — | — | Adult Solid Neoplasm,Lymphoma,Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00104767Phase 1 · completed Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 194 trials list this drug (15 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02537925Phase 3 · unknown The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma · 194 trials list this drug (15 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00201773Phase 2 · completed Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer · 194 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00230399Phase 2 · completed Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01021215Phase 1/Phase 2 · completed Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068770Phase 2 · terminated Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02343614Phase 2 · completed Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00108186Phase 1 · withdrawn Celecoxib Treatment for Lung Cancer · 194 trials list this drug (15 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00088959Phase 1 · completed Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 194 trials list this drug (15 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357500Phase 2 · completed Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer · 194 trials list this drug (15 active) | — | — | Childhood Solid Neoplasm,Leukemia,Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00698204Phase 2 · completed Cox-2 Inhibition in Radiation-induced Oral Mucositis · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00061906Phase 2 · completed Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer · 194 trials list this drug (15 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006381Phase 2 · completed Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer · 194 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00589186Phase 2 · unknown Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer · 194 trials list this drug (15 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00023660Phase 1/Phase 2 · completed Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer · 194 trials list this drug (15 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072540Phase 2 · withdrawn S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix · 194 trials list this drug (15 active) | — | — | High Grade Squamous Intraepithelial Neoplasia,Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072072Phase 1 · completed Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 194 trials list this drug (15 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084370NA · withdrawn Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy · 194 trials list this drug (15 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027976Phase 2/Phase 3 · withdrawn Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084578NA · withdrawn Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder · 194 trials list this drug (15 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101335Phase 2 · completed Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia · 194 trials list this drug (15 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084448Phase 2 · terminated Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer · 194 trials list this drug (15 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00023621Phase 2 · completed Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome · 194 trials list this drug (15 active) | — | — | Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00043043Phase 2 · completed Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00062101Phase 2 · completed Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer · 194 trials list this drug (15 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00653250NA · completed Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer · 194 trials list this drug (15 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00808743Phase 2/Phase 3 · completed Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis · 194 trials list this drug (15 active) | — | — | Duodenal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030407Phase 2 · completed Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer · 194 trials list this drug (15 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030420Phase 2 · completed Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer · 194 trials list this drug (15 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068653Phase 2 · completed Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer · 194 trials list this drug (15 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00581971Phase 1/Phase 2 · completed Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer · 194 trials list this drug (15 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005094Phase 3 · completed Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps · 194 trials list this drug (15 active) | — | — | Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00258232Phase 2 · completed Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025051Phase 2 · withdrawn Celecoxib in Preventing Skin Cancer · 194 trials list this drug (15 active) | — | — | Basal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00336960Phase 2 · completed Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00608595NA · terminated Celecoxib in Treating Patients With Early-Stage Rectal Cancer · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006124Phase 2/Phase 3 · completed Celecoxib in Treating Patients With Bladder Cancer · 194 trials list this drug (15 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084721Phase 1 · completed Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014404Phase 2 · completed Celecoxib in Treating Patients With Precancerous Lesions of the Mouth · 194 trials list this drug (15 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087256Phase 3 · terminated Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00466505Phase 2 · completed Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00527982Phase 2 · terminated Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer · 194 trials list this drug (15 active) | — | — | Malignant Head and Neck Neoplasm,Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00551005Phase 1 · completed Etoposide and Celecoxib in Patients With Advanced Cancer · 194 trials list this drug (15 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00551889Phase 1 · completed Cyclophosphamide and Celecoxib in Treating Patients With Advanced Cancer · 194 trials list this drug (15 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00346801Phase 1 · completed CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC) · 194 trials list this drug (15 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00064181Phase 3 · completed Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00293436Phase 1/Phase 2 · withdrawn Celecoxib and Erlotinib in Treating Patients With Liver Cancer · 194 trials list this drug (15 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00592319Phase 2 · terminated Celebrex (Celecoxib) Treatment of Laryngeal Papilloma · 194 trials list this drug (15 active) | — | — | Laryngeal Squamous Papilloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01158534Phase 2 · completed Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery · 194 trials list this drug (15 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00981201Phase 3 · completed Celecoxib as a Chemopreventive Agent in Current and Former Smokers · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00073866Phase 1/Phase 2 · completed Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer · 194 trials list this drug (15 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00057980Phase 1/Phase 2 · completed Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma · 194 trials list this drug (15 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00058006Phase 2 · completed Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer · 194 trials list this drug (15 active) | — | — | Malignant Head and Neck Neoplasm,Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00073970Phase 2 · terminated Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy · 194 trials list this drug (15 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00520091Phase 2 · completed Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer · 194 trials list this drug (15 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00231829Phase 2 · terminated A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers · 194 trials list this drug (15 active) | — | — | Malignant Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00504660Phase 2 · completed 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients · 194 trials list this drug (15 active) | — | — | Glioblastoma,Brain Neoplasm,Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01503385Phase 2 · unknown Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC) · 194 trials list this drug (15 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00165451Phase 2 · completed A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer · 194 trials list this drug (15 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00525096Phase 3 · completed Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer · 194 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00055978Phase 2 · completed Celecoxib in Preventing Lung Cancer in Former Heavy Smokers · 194 trials list this drug (15 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101062Phase 2 · terminated Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer · 194 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357617Phase 1/Phase 2 · unknown Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery · 194 trials list this drug (15 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00188565Phase 1/Phase 2 · completed Celebrex With Preoperative Chemoradiation - Rectal Cancer · 194 trials list this drug (15 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00177853Phase 1 · terminated Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer · 194 trials list this drug (15 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00136487Phase 2/Phase 3 · completed Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer · 194 trials list this drug (15 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00066716Phase 2 · completed Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus · 194 trials list this drug (15 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00181532Phase 2 · completed Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC · 194 trials list this drug (15 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00300729Phase 3 · unknown Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy · 194 trials list this drug (15 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072553Phase 2 · unknown Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer · 194 trials list this drug (15 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00274898Phase 2 · unknown Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer · 194 trials list this drug (15 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00036283Phase 2 · completed Chemoprevention of Oral Premalignant Lesions · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00037180Phase 2 · terminated For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy · 194 trials list this drug (15 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00328432Phase 1 · completed A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy · 194 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00291122completed An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast Cancer · 194 trials list this drug (15 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00176813Phase 2 · completed Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer · 194 trials list this drug (15 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001693Phase 1 · completed Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers · 194 trials list this drug (15 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001955Phase 2 · completed Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions) · 194 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00603759Phase 3 · unknown COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma · 194 trials list this drug (15 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00486460Phase 3 · unknown Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer · 194 trials list this drug (15 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00295035Phase 3 · unknown Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer · 194 trials list this drug (15 active) | — | — | Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00215345Phase 2 · unknown A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer · 194 trials list this drug (15 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00218205Phase 2 · unknown A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer · 194 trials list this drug (15 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00211952Phase 3 · suspended Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients · 194 trials list this drug (15 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |